GEA Pharma Presents Update On ConsiGma Continuous Tableting Line
The presentation emphasized that in the view of the FDA the use of continuous processing in pharmaceutical production will lead to an improvement in product quality. A further

The presentation emphasized that in the view of the FDA the use of continuous processing in pharmaceutical production will lead to an improvement in product quality. A further

Earlier, COTI had entered into this partnership to advance its HIV-1 integrase inhibitor program. As per the agreement, COTI retains all data and intellectual property ownership of the

The study, funded by the National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health, is part of a multicenter research project

Onko-Sure is a simple, non-invasive, patent-pending and regulatory-approved in vitro test for use as an aid in early detection of cancer that enables physicians and their patients to

Xoma said that one of the patents covers methods of treating type 2 diabetes with high affinity antibodies and antibody fragments that bind to IL-1 beta, including Xoma

Metabolex is expected to work with TSF on the evaluation and validation of protein targets for the development of biological products. Metabolex will provide novel protein targets discovered

It is anticipated that the review process in Argentina is expected to be completed within a fast-tracked period of no less than six months from the filing of

Clobex is a topical steroid indicated to treat moderate to severe plaque psoriasis in patients 18 years and older. Clobex Spray comes in 2oz and 4.25oz bottles with

Further to the addition of the new drug delivery system, the company has named Edgar Jaynes as its associate director of pharmaceutical development services. Dr Jaynes comes to

The Germany-based company recently invested in the expansion of the Chilworth Technical Centre, its chemicals research site in Southampton, UK, by adding new laboratories to intensify and hasten